99
Participants
Start Date
February 10, 2023
Primary Completion Date
November 9, 2023
Study Completion Date
November 9, 2023
CS0159 (Linafexor)
Oral QD
Lucas Research, Morehead City
Oracle Clinical Research, College Park
Ocala GI Research, Lady Lake
Gastroenterology Associates of Ocala, Ocala
Metropolitan Gastroenterology Associates - Westbank Office and Endoscopy, Marrero
The Texas Liver Institute, Inc., San Antonio
Clinical Trials of Texas, LLC, San Antonio
Velocity Clinical Research - Santa Ana, Santa Ana
National Research Institute - Gardena, Gardena
Velocity Clinical Research, Huntington Park, Huntington Park
Velocity Clinical Research - Panorama City, Panorama City
Florida Research Institute, Lakewood
San Marcus Research Clinic, Inc - Miami, Miami
Floridian Clinical Research, LLC - Miami Lakes, Miami Lakes
Raja M. Din MD, PLLC - Gastroenterology & Hepatology, Greenbelt
Texas Liver Institute (TLI) - Austin, Austin
Pioneer Research Solutions Inc - Houston - Stancliff Rd, Houston
Lead Sponsor
Laboratory Corporation of America
INDUSTRY
Cascade Pharmaceuticals, Inc
OTHER